Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease

Journal of Virology

Volumn 76, Issue 20, 2002, Pages 10226-10233

  Pettit, Steve C ^a   Henderson, Gavin J ^a   Schiffer, Celia A ^a   Swanstrom, Ronald ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; GAG PROTEIN; LEUCINE; METHIONINE; PROTEINASE; TYROSINE; VIRUS DNA;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DNA TRANSCRIPTION; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; RNA TRANSLATION; SITE DIRECTED MUTAGENESIS; VIRION; WESTERN BLOTTING;

BINDING SITES; GENE PRODUCTS, GAG; HIV PROTEASE; HIV-1; HUMANS; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 0036784575     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.20.10226-10233.2002     Document Type: Article

References (61)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Bebenek, K., and T. A. Kunkel. 1989. The use of native T7 DNA polymerase for site-directed mutagenesis. Nucleic Acids Res. 17:5408.
3. Billich, A., and G. Winkler. 1991. Analysis of subsite preferences of HIV-1 proteinase using MA/CA junction peptides substituted at the P3-P1′ positions. Arch. Biochem. Biophys. 290:186-190.
4. Billich, S., M. T. Knoop, J. Hansen, P. Strop, J. Sedlacek, R. Mertz, and K. Moelling. 1988. Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease. J. Biol. Chem. 263:17905-17908.
5. Cameron, C. E., B. Grinde, P. Jacques, J. Jentoft, J. Leis, A. Wlodawer, and I. T. Weber. 1993. Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases. J. Biol. Chem. 268:11711-11720.
6. Chen, C., and H. Okayama. 1987. High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2754-2762.
7. Darke, P. L., R. F. Nutt, S. F. Brady, V. M. Garsky, T. M. Ciccarone, C. T. Leu, P. K. Lumma, R. M. Freidinger, D. F. Veber, and I. S. Sigal. 1988. HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins. Biochem. Biophys. Res. Commun. 156:297-303.
8. Doyon, L., G. Croteau, D. Thibeault, F. Poulin, L. Pilote, and D. Lamarre. 1996. Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors. J. Virol. 70:3763-3769.
9. Erickson-Viitanen, S., J. Manfredi, P. Viitanen, D. E. Tribe, R. Tritch, C. A. Hutchison III, D. D. Loeb, and R. Swanstrom. 1989. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease. AIDS Res. Hum. Retroviruses 5:577-591.
10. Gitti, R. K., B. M. Lee, J. Walker, M. F. Summers, S. Yoo, and W. I. Sundquist. 1996. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273:231-235.
11. Gottlinger, H. G., J. G. Sodroski, and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of the human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86: 5781-5785.
12. Gowda, S., B. Stein, and E. Engleman. 1989. Identification of protein intermediates in the processing of the p55 HIV-1 Gag precursor in cells infected with recombinant vaccinia virus. J. Biol. Chem. 264:8459-8462.
13. Griffiths, J. T., L. H. Phylip, J. Konvalinka, P. Strop, A. Gustchina, A. Wlodawer, R. J. Davenport, R. Briggs, B. M. Dunn, and J. Kay. 1992. Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites. Biochemistry 31:5193-5200.
14. Grinde, B., C. E. Cameron, J. Leis, I. T. Weber, A. Wlodawer, H. Burstein, and A. M. Skalka. 1992. Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates. J. Biol. Chem. 267:9491-9498.
15. Mnc). J. Virol. 62:2587-2595.
16. Henderson, L. E., M. A. Bowers, R. d. Sowder, S. A. Serabyn, D. G. Johnson, J. J. Bess, L. O. Arthur, D. K. Bryant, and C. Fenselau. 1992. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences. J. Virol. 66:1856-1865.
17. Henderson, L. E., R. C. Sowder, T. D. Copeland, S. Oroszlan, and R. E. Benveniste. 1990. Gag precursors of HIV and SIV are cleaved into six proteins found in the mature virions. J. Med. Primatol. 19:411-419.
18. Jacks, T., M. D. Power, F. R. Masiarz, P. A. Luciw, P. J. Barr, and H. E. Varmus. 1988. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature 331:280-283.
19. Jupp, R. A., L. H. Phylip, J. S. Mills, F. J. Stuart, S. F. Le Grice, and J. Kay. 1991. Mutating P2 and P1 residues at cleavage junctions in the HIV-1 pol polyprotein. Effects on hydrolysis by HIV-1 proteinase. FEBS Lett. 283:180-184.
20. Kaplan, A. H., M. Manchester, and R. Swanstrom. 1994. The activity of the protease of HIV-1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. J. Virol. 68:6782-6786.
21. Karacostas, V., E. J. Wolffe, K. Nagashima, M. A. Gonda, and B. Moss. 1993. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. Virology 193:661-671.
22. Kassel, D. B., M. D. Green, R. S. Wehble, R. Swanstrom, and J. Berman. 1995. HIV-1 protease specificity derived from a complex mixture of synthetic substrates. Anal. Biochem. 228:259-266.
23. Krausslich, H. G. 1992. Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation. J. Virol. 66:567-572.
24. Krausslich, H. G., R. H. Ingraham, M. T. Skoog, E. Wimmer, P. V. Pallai, and C. A. Carter. 1989. Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides. Proc. Natl. Acad. Sci. USA 86:807-811.
25. Kunkel, T. A., K. Bebenek, and J. McClary. 1991. Efficient site-directed mutagenesis using uracil-containing DNA. Methods Enzymol. 204:125-139.
26. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacterophage T4. Nature 277:680-685.
27. Louis, J. M., I. T. Weber, J. Tozser, G. M. Clore, and A. M. Gronenborn. 2000. HIV-1 protease: maturation, enzyme specificity, and drug resistance. Adv. Pharmacol. 49:111-146.
28. Mammano, F., C. Petit, and F. Clavel. 1998. Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients. J. Virol. 72:7632-7637.
29. Mervis, R. J., N. Ahmad, E. P. Lillehoj, M. G. Raum, F. H. Salazar, H. W. Chan, and S. Venkatesan. 1988. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J. Virol. 62:3993-4002.
30. Moore, M. L., W. M. Bryan, S. A. Fakhoury, V. W. Magaard, W. F. Huffman, B. D. Dayton, T. D. Meek, L. Hyland, G. B. Dreyer, B. W. Metcalf, J. E. Strickler, J. G. Gorniak, and C. Debouck. 1989. Peptide substrates and inhibitors of the HIV-1 protease. Biochem. Biophys. Res. Comm. 159:420-425.
31. Nakai, M., and T. Goto. 1996. Ultrastructure and morphogenesis of human immunodeficiency virus. J. Electron Microsc. 45:247-257.
32. Olsen, J. C., and R. Swanstrom. 1985. A new pathway in the generation of defective retrovirus DNA. J. Virol. 56:779-789.
33. Oroszlan, S., and T. B. Luftig. 1990. Retroviral proteinases. Curr. Top. Microbiol. Immunol. 157:153-185.
34. Partin, K., H. G. Krausslich, L. Ehrlich, E. Wimmer, and C. Carter. 1990. Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase. J. Virol. 64:3938-3947.
35. Pettit, S. C., M. S. Horwitz, and J. A. Engler. 1989. Mutations of the precursor to the terminal protein of adenovirus serotypes 2 and 5. J. Virol. 63:5244-5250.
36. Pettit, S. C., M. D. Moody, R. S. Wehbie, A. H. Kaplan, P. V. Nantermet, C. A. Klein, and R. Swanstrom. 1994. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol. 68:8017-8027.
37. Pettit, S. C., J. Simsic, D. D. Loeb, L. Everitt, C. A. Hutchison III, and R. Swanstrom. 1991. Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J. Biol. Chem. 266:14539-14547.
38. Phylip, L. H., A. D. Richards, J. Kay, J. Kovalinka, P. Strop, I. Blaha, J. Velek, V. Kostka, A. J. Ritchie, A. V. Broadhurst, W. G. Farmerie, P. E. Scarborough, and B. M. Dunn. 1990. Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases. Biochem. Biophys. Res. Commun. 171:439-444.
39. Poorman, R. A., A. G. Tomasselli, R. L. Heinrikson, and F. J. Kezdy. 1991. A cumulative specificity model of proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base. J. Biol. Chem. 266:14554-14561.
40. Prabu-Jeyabalan, M., E. Nalivaika, and C. A. Schiffer. 2000. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J. Mol. Biol. 301:1207-1220.
41. Prabu-Jeybalan, M. M., E. Nalivaika, and C. A. Schiffer. 2001. Substrate shape determines specificity of recognition for HIV-1 protease: Analysis of crystal structures of six substrate complexes. Structure 10:369-381.
42. Ratner, L., A. Fisher, L. L. Jagodzinski, H. Mitsuya, R.-S. Liou, R. C. Gallo, and F. Wong-Staal. 1987. Complete nucleotide sequences of functional clones of the AIDS virus. AIDS Res. Hum. Retroviruses 3:57-69.
43. Richards, A. D., L. H. Phylip, W. G. Farmerie, P. E. Scarborough, A. Alvarez, B. M. Dunn, P. H. Hirel, J. Konvalinka, P. Strop, L. Pavlickova, V. Kostka, and J. Kay. 1990. Sensitive, soluble chromogenic substrates for HIV-1 proteinase. J. Biol. Chem. 265:7733-7736.
44. Ridky, T. W., C. E. Cameron, J. Cameron, J. Leis, T. Copeland, A. Wlodawer, I. T. Weber, and R. W. Harrison. 1996. Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites. J. Biol. Chem. 271:4709-4717.
45. Ridky, T. W., A. Kikonyogo, J. Leis, S. Gulnik, T. Copeland, J. Erickson, A. Wlodawer, I. Kurinov, R. W. Harrison, and I. T. Weber. 1998. Drug-resistant HIV-1 proteases identify enzyme residues important for substrate selection and catalytic rate. Biochemistry 37:13835-13845.
46. Schagger, H., and G. von Jagow. 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368-379.
47. Schatz, G., I. Pichova, and V. M. Vogt. 1997. Analysis of cleavage site mutations between the NC and PR Gag domains of Rous sarcoma virus. J. Virol. 71:444-450.
48. Sheng, N., and S. Erickson-Viitanen. 1994. Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent. J. Virol. 68:6207-6214.
49. Sheng, N., S. C. Pettit, R. J. Tritch, D. H. Ozturk, M. M. Rayner, R. Swanstrom, and V. S. Erickson. 1997. Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease. J. Virol. 71:5723-5732.
50. Swanstrom, R., and J. Wills. 1997. Retroviral gene expression: synthesis, processing, and assembly of viral proteins, p. 263-334. In H. E. Varmus, J. Coffin, and S. Hughes (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
51. Tomasselli, A. G., J. O. Hui, T. K. Sawyer, D. J. Staples, C. Bannow, I. M. Reardon, W. J. Howe, D. L. DeCamp, C. S. Craik, and R. L. Heinrikson. 1990. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2. J. Biol. Chem. 265:14675-14683.
52. Tozser, J., I. Blaha, T. D. Copeland, E. M. Wondrak, and S. Oroszlan. 1991. Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins. FEBS Lett. 281:77-80.
53. Tozser, J., A. Gustchina, I. T. Weber, I. Blaha, E. M. Wondrak, and S. Oroszlan. 1991. Studies on the role of the S4 substrate binding site of HIV proteinases. FEBS Lett. 279:356-360.
54. Tozser, J., I. T. Weber, A. Gustchina, I. Blaha, T. D. Copeland, J. M. Louis, and S. Oroszlan. 1992. Kinetic and modeling studies of S3-S3′ subsites of HIV proteinases. Biochemistry 31:4793-4800.
55. Tritch, R. J., Y. E. Cheng, F. H. Yin, and S. Erickson-Viitanen. 1991. Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein. J. Virol. 65:922-930.
56. Veronese, F. D., R. Rahman, T. D. Copeland, S. Oroszlan, R. C. Gallo, and M. G. Sarngadharan. 1987. Immunological and chemical analysis of p6, the carboxyl-terminal fragment of HIV p15. AIDS Res. Hum. Retroviruses 3:253-264.
57. von Schwedler, U. K., T. L. Stemmler, V. Y. Klishko, S. Li, K. H. Albertine, D. R. Davis, and W. I. Sundquist. 1998. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 17:1555-1568.
58. Wiegers, K., G. Rutter, H. Kottler, U. Tessmer, H. Hohenberg, and H. G. Krausslich. 1998. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J. Virol. 72:2846-2854.
59. Wilson, W., M. Braddock, S. E. Adams, P. D. Rathjen, S. M. Kingsman, and A. J. Kingsman. 1988. HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems. Cell 55:1159-1169.
60. Wlodawer, A., and J. W. Erickson. 1993. Structure-based inhibitors of HIV-1 protease. Annu. Rev. Biochem. 62:543-585.
61. Zhang, Y. M., H. Imamichi, T. Imamichi, H. C. Lane, J. Falloon, M. B. Vasudevachari, and N. P. Salzman. 1997. Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites. J. Virol. 71:6662-6670.